Post-renal transplant obstruction caused by cytomegalovirus ureteritis [3]

Nephrology Dialysis Transplantation

Volumn 15, Issue 12, 2000, Pages 2063-2064

  Leikis, Murray J ^a   Denford, Aran J B ^a   Pidgeon, Grant B ^a   Hatfield, Peter J ^a  

^a WELLINGTON HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; HLA DR ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS ANTIBODY;

ADULT; CADAVER KIDNEY; CASE REPORT; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CYTOMEGALOVIRUS INFECTION; HUMAN; HYDRONEPHROSIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; MALE; NEPHROSTOMY; PRIORITY JOURNAL; URETER DISEASE; URETER OBSTRUCTION; URETER STENT;

EID: 0033659318     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.12.2063-a     Document Type: Letter

References (6)

1. Infectious disease complications of renal transplantation
2. Invasive cytomegalovirus infection in a renal transplant ureter after combined pancreas-kidney transplantation: An unusual cause of renal allograft dysfunction
3. Ureteritis and cholecystitis: Two unusual manifestations of cytomegalovirus disease in renal transplant recipients
4. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation
5. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody
6. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients